Again, another study that proves the right direction of IMU with CF33. Only difference again is, we are already in human trial. What's more it is quite easy (I am talking in relative sense here) to find a virus to do this job but the difficult part is finding one that is both effective and safe for patients. Safety in fact is paramount.
So again, so glad I am on the IMU train. We are so far ahead of the curve no wonder LC is so excited in her recent interviews!
Ann: Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx, page-161
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
-0.006(8.82%) |
Mkt cap ! $455.6M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.2¢ | $3.774M | 58.30M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3402693 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 610000 | 3 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |